PPIDT00261
Drug Information
| Name | Corifollitropin alfa |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB09066 |
| Type | biotech |
| Indication | Controlled ovarian stimulation [L2273] in cases of women who are undergoing fertility treatment to stimulate the development of more than one mature egg simultaneously in the ovaries in combination with a gonadotrophin-releasing hormone (GnRH) antagonist (a type of medicine also used in fertility treatments)[L2270]. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, solution | Parenteral; Subcutaneous |
100 MCG
|
| Injection, solution | Parenteral; Subcutaneous |
150 MCG
|
| Injection, solution | Subcutaneous |
100 micrograms
|
| Injection, solution | Subcutaneous |
150 micrograms
|
| Injection | — |
100 mcg/0.5ml
|
| Injection, solution | — |
100 mcg/0.5ml
|
| Injection, solution | — |
150 mcg/0.5ml
|
| Injection, solution | Subcutaneous |
0.100 mg
|
| Injection, solution | Subcutaneous |
0.150 mg
|
| Solution | Subcutaneous |
10000000 mcg
|
| Solution | Subcutaneous |
33 cg
|
| Solution | Subcutaneous |
|
| Solution | Subcutaneous |
900 IU
|
| Solution | Subcutaneous |
100.000 mcg
|
| Solution | Subcutaneous |
100 mcg/0.5ml
|
| Solution | Subcutaneous |
150 mcg/0.5ml
|